Log in

Relevant bibliographies by topics / COVID-19 (coronavirus disease 2019) / Journal articles

Journal articles on the topic 'COVID-19 (coronavirus disease 2019)'

To see the other types of publications on this topic, follow the link: COVID-19 (coronavirus disease 2019).

Author: Grafiati

Published: 10 December 2022

Last updated: 28 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'COVID-19 (coronavirus disease 2019).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Aysha Azhar. "CORONAVIRUS DISEASE 2019 (COVID-19)." Journal of University Medical & Dental College 11, no. 3 (September 25, 2020): v—vi. http://dx.doi.org/10.37723/jumdc.v11i3.487.

Full text

Abstract:

The epidemic of 2019 novel coronavirus (2019-nCoV) has been emerged from a major city named Wuhan in the Hubei Province of China. It appears to have the potential to cause a major health problem globally. Earlier it is called 2019-nCoV but now this virus is taxonomically termed SARS-CoV-2. World Health Organization has named it as “coronavirus disease 2019” and abbreviated “COVID-19” [1].

APA, Harvard, Vancouver, ISO, and other styles

2

Goldust, Mohamad. "Coronavirus Disease 2019 (COVID-19)." Biology 11, no. 8 (August 22, 2022): 1250. http://dx.doi.org/10.3390/biology11081250.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Xiang, Kai Yan, Zi Yue Zu, Guang Ming Lu, and Long Jiang Zhang. "Coronavirus Disease 2019 (COVID-19)." Journal of Thoracic Imaging 35, no. 4 (May 1, 2020): 234–38. http://dx.doi.org/10.1097/rti.0000000000000528.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Aminul Hoque, AKM. "Coronavirus disease 2019 (COVID-19)." Anwer Khan Modern Medical College Journal 11, no. 2 (August 10, 2020): 89–90. http://dx.doi.org/10.3329/akmmcj.v11i2.62749.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sadeghi Dousari, Amin, Majid Taati Moghadam, and Naghmeh Satarzadeh. "COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease." Infection and Drug Resistance Volume 13 (August 2020): 2819–28. http://dx.doi.org/10.2147/idr.s259279.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Seo, Jun-Won, Da-Young Kim, Nara Yun, and Dong-Min Kim. "Coronavirus Disease 2019-Associated Coagulopathy." Microorganisms 10, no. 8 (August 2, 2022): 1556. http://dx.doi.org/10.3390/microorganisms10081556.

Full text

Abstract:

Coronavirus disease 2019 (COVID-19)-associated coagulopathy is an acute illness characterized by thrombosis with or without hemorrhage after COVID-19 infection. Clinical symptoms of COVID-19-associated coagulopathy can occur at any anatomical site. Various forms of venous thromboembolism, including deep vein thrombosis and pulmonary embolism, are common in acutely ill patients with COVID-19. Laboratory findings, such as D-dimer and platelet counts, can help diagnose COVID-19-associated coagulopathy. Anticoagulation using direct oral anticoagulants and low-molecular-weight heparin is essential for the treatment of COVID-19-associated coagulopathy. Prophylactic anticoagulants are important in preventing COVID-19-associated coagulopathy in patients with severe COVID-19. In particular, the early initiation of prophylactic anticoagulation in patients with COVID-19 can improve survival rates without the risk of serious bleeding events.

APA, Harvard, Vancouver, ISO, and other styles

7

Saini, Mahendra, Nikhita Parihar, Shankar Lal Soni, and Vandana Sharma. "Coronavirus Disease-2019 (COVID-19): An Overview." Asian Journal of Pharmaceutical Research and Development 9, no. 1 (February 15, 2021): 202–5. http://dx.doi.org/10.22270/ajprd.v9i1.896.

Full text

Abstract:

There is a new public health crises threatening the world with the emergence and unfold of two019 novel coronavirus (2019-nCoV) or the severe acute metabolism syndrome coronavirus two (SARS-CoV-2). COVID-19 is a spread of coronavirus is the family Coronaviridae. The malady is believed to originate from crackers Associate in Nursing was unfold to people through unknown medium in an exceedingly town, China. Severe acute metabolism syndrome coronavirus 2 (SARS- CoV-2) could also be a very transmissible and infective coronavirus that emerged in late 2019 and has caused an outbreak|avirus|a virulent disease|a pestilence} of acute disease, named, ‘coronavirus malady 2019’ (COVID-19), that threatens human health and public safety. throughout this Review, we have a tendency to to tend to explain the essential medicine of SARS- CoV-2, together with genomic characteristics, and receptor use, lightness its key distinction from antecedent acquainted coronaviruses. we have a tendency to to tend to summarize current data of clinical, medicine, and pathological choices of COVID-19, additionally as recent progress in animal models, and antiviral treatment approach for SARS- CoV-2 infection. we have a tendency to to tend to to boot discuss the potential life hosts and disease origin of this rising virus well.

APA, Harvard, Vancouver, ISO, and other styles

8

Gerloff, Christian, Peter Berlit, and Christine Klein. "COVID-19(„coronavirus disease 2019“)-Impfung." DGNeurologie 4, no. 2 (February 23, 2021): 75–77. http://dx.doi.org/10.1007/s42451-021-00309-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hageman, Joseph R. "The Coronavirus Disease 2019 (COVID-19)." Pediatric Annals 49, no. 3 (March 1, 2020): e99-e100. http://dx.doi.org/10.3928/19382359-20200219-01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sorace, Paul, James R. Churilla, Thomas P. Mahady, and William O. Roberts. "Coronavirus Disease 2019 (COVID-19) Infection." ACSM'S Health & Fitness Journal 24, no. 6 (November 2020): 48–50. http://dx.doi.org/10.1249/fit.0000000000000617.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Shapiro, Janet M. "Having Coronavirus Disease 2019 (COVID-19)." JAMA Cardiology 5, no. 10 (October 1, 2020): 1091. http://dx.doi.org/10.1001/jamacardio.2020.3247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Hidayat, Rachmat, and Patricia Wulandari. "The New Emerging Disease COVID-19 (Coronavirus Disease 2019)." Open Access Indonesian Journal of Medical Reviews 2, no. 6 (August 16, 2022): 315–18. http://dx.doi.org/10.37275/oaijmr.v2i6.240.

Full text

Abstract:

COVID-19 (Coronavirus disease 2019) is a new type of disease caused by a virus from the coronavirus group, namely the Severe Acute Respiratory Syndrome Coronavirus 2 or SARS-CoV-2. COVID-19 can cause respiratory system disorders, ranging from mild symptoms such as flu to lung infections, such as pneumonia. Coronaviruses are single-stranded and positive-chain RNA viruses with a particle size of 120-160 nm. This virus in humans attacks the respiratory tract, especially in the cells lining the alveoli. This virus mainly infects animals, including bats and camels.

APA, Harvard, Vancouver, ISO, and other styles

13

ORHAN KUBAT, Gözde, and Caner ŞAHİN. "Coronavirus Disease-2019 (COVID-19) Clinical Features." Kulak Burun Boğaz ve Baş Boyun Cerrahisi Dergisi 28, no. 2 (2020): 14–19. http://dx.doi.org/10.24179/kbbbbc.2020-75703.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Kiay, Megawati, Olivia C. P. Pelealu, and Steward K. Mengko. "Anosmia pada Coronavirus Disease 2019 (Covid-19)." JURNAL BIOMEDIK (JBM) 13, no. 2 (March 29, 2021): 167. http://dx.doi.org/10.35790/jbm.13.2.2021.31827.

Full text

Abstract:

Abstrack: COVID-19 is a disease caused by Coronaviruses (CoVs). WHO has declared the prevalence of COVID-19 as a Public Health Emergency of International Concern (PHEIC). The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have listed symptoms of anosmia or loss of smell as one of the symptoms of COVID-19 that worth watching out for. This study aims to determine whether there is a relationship between anosmia and the 2019 coronavirus disease (COVID-19). Using the Literature review method, which is carried out by identifying, evaluating and interpreting all the results of certain studies which are the focus of the research. Anosmia is one of the earliest signs of COVID-19 infection with an average onset of 7 days. Symptoms can appear just before, with or immediately after the onset of the usual symptoms, with an average recovery of 14 days. Most patients do not experience nasal congestion or rhinorrhea. There is a relationship between anosmia and coronavirus disease 2019 (COVID-19). Anosmia was found as an early sign of Coronavirus Disease (Covid-19) infection with the average duration of anosmia is 7 days and the results appear to be favorable in less than 28 days. The mechanism of the olfactory disturbance by COVID-19 is not explained. One hypothesis is that SARS-CoV-2 will cause a change of smell through direct access and damage to the CNS through its penetration by the cribriform plate. Another hypothesis is direct viral damage to olfactory cells and taste receptors.Key words: Anosmia, loss of smell, olfactory disorder, coronavirus disease 2019, COVID-19, SARS-Cov2. Abstrak: COVID-19 adalah penyakit yang di sebabkan Coronaviruses (CoVs). WHO telah menyatakan prevalensi COVID-19 sebagai Public Health Emergency of International Concern (PHEIC).World Health Organization (WHO) dan Centers for Disease Control and Prevention(CDC) telah mencantumkan gejala anosmia atau kehilangan kemampuan penciuman sebagai salah satu gejala COVID-19 yang patut diwaspadai. Penelitian ini bertujuan untuk mengetahui apakah ada hubungan anosmia dengan coronavirus disease 2019 (COVID-19). Menggunakan metode Literature review yang di lakukan dengan cara identifikasi, evaluasi dan interpretasi terhadap semua hasil penelitian tertentu yang menjadi fokus penelitian. Anosmia adalah salah satu tanda awal infeksi COVID-19 dengan rata-rata onset 7 hari. Gejala dapat muncul tepat sebelum, bersamaan atau segera setelah timbulnya gejala yang biasa, dengan rata-rata pemulihan 14 hari. Kebanyakan pasien tidak mengalami hidung tersumbat atau rinorea. Ada hubungan antara anosmia dengan coronavirus disease 2019 (COVID-19). Dimana Anosmia di temukan sebagai tanda awal infeksi Coronavirus Disease (Covid-19) dengan durasi rata-rata anosmia adalah 7 hari dan hasilnya tampak menguntungkan dalam waktu kurang dari 28 hari. Mekanisme gangguan penciuman oleh COVID-19 tidak dijelaskan. Salah satu hipotesis adalah bahwa SARS-CoV-2 akan menyebabkan perubahan penciuman melalui akses langsung dan kerusakan pada SSP melalui penembusannya oleh pelat kribriform. Hipotesis lain adalah kerusakan virus langsung pada sel penciuman dan reseptor rasa. Kata Kunci : Anosmia, loss of smell, olfactory disorder, coronavirus disease 2019, COVID-19, SARS-Cov2.

APA, Harvard, Vancouver, ISO, and other styles

15

Carvalho, Jozélio Freire de. "Coronavirus disease 2019 (covid-19) and rheumatic diseases." Revista de Ciências Médicas e Biológicas 19, no. 1 (June 19, 2020): 3. http://dx.doi.org/10.9771/cmbio.v19i1.36903.

Full text

Abstract:

<p>At the end of December 2019, a new viral infection never before described appeared in the city of Wuhan, Hubei province, China, leading to a percentage of cases of severe respiratory failure. It was very quickly investigated and its etiological agent was discovered, being a new betacoronavirus, called Severe Acute Respiratory Coronavirus 2 Syndrome (SARS-Cov 2), to differentiate it from the SARS-Cov, reported in the period from 2000 to 2004, and another similar disease also caused by coronavirus, after ten years - Middle East Respiratory Syndrome Coronavirus (MERS-Cov). The disease caused by the virus came to be called Coronavirus Disease 2019 (Covid-19). After leaving China, this disease spread to several countries in the world, culminating in March, when the World Health Organization (WHO) declared a state of pandemic <sup>(1)</sup>. The coronavirus is characterized by presenting RNA with a single helix and on its viral surface presents, to electron microscope, a structure that look like a crown, hence the name corona. A probable mutation happened from wild sources, which could be the origin of bats or snakes. Eating meat from the wild animal market, a tradition in China, was once again responsible for a major epidemic <sup>(1)</sup>.</p>

APA, Harvard, Vancouver, ISO, and other styles

16

Linardi, Jade Irene. "Coronavirus disease 2019 in neonates." International Journal of Contemporary Pediatrics 8, no. 4 (March 23, 2021): 773. http://dx.doi.org/10.18203/2349-3291.ijcp20211095.

Full text

Abstract:

Coronavirus disease 2019 (COVID-19) as a global pandemic has become a major burden especially in the health care system and economy. COVID-19 has clinical presentations ranging from remain asymptomatic to severe acute respiratory distress syndrome (ARDS) and death. All age groups are susceptible to this virus, but it seems that children with COVID-19 have milder symptoms than adults. Neonates, however, have been reported to have more severe cases compared to older children. There is also a possibility of vertical transmission from mothers to their neonates which could not be ignored. This review provides current knowledge of COVID-19 in neonates.

APA, Harvard, Vancouver, ISO, and other styles

17

Prahalad, Ajna, and Varun Soti. "Coronavirus disease 2019: an overview." International Journal Of Community Medicine And Public Health 8, no. 10 (September 27, 2021): 5094. http://dx.doi.org/10.18203/2394-6040.ijcmph20213821.

Full text

Abstract:

Coronavirus disease 2019 (COVID-19) has caused over four million deaths worldwide and continues to affect millions across the globe. This review aims to provide an overview of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the progress made to counter COVID-19 through therapeutics and immunizations. We searched preclinical and clinical COVID-19 literature published between January 2018 through June 2021 on PubMed. The medical subject headings used in the literature search were COVID-19, SARS-CoV-2, Treatment, Remdesivir, Cytokine Storm, Hydroxychloroquine, Epidemiology, Angiotensin-Converting Enzyme 2 Receptor, Vaccines, and Mitigation. There is credible evidence that shows that the spike protein in the SARS-CoV-2’s structure is crucial for the host to be infected. It spreads through different modes, primarily through aerosols and carriers. Pathophysiologically, SARS-CoV-2 triggers a cytokine storm leading to systemic inflammation, which can be fatal. Although treatment with Remdesivir and Dexamethasone and massive vaccinations have significantly reduced the mortality rate, COVID-19 remains a significant threat. The emergence of SARS-CoV-2’s different strains, notably the Delta variant, demonstrates that the COVID-19 pandemic is not over. More vaccine distribution and increased efforts in developing anti-SARS-CoV-2 drugs, social distancing, masking, and practicing good hygiene will be crucial in defeating COVID-19.

APA, Harvard, Vancouver, ISO, and other styles

18

Kishore, Jugal. "Frequently Asked Questions (FAQs) about Coronavirus Disease 2019 (Covid-19)." Epidemiology International 05, no. 01 (March 19, 2020): 14–21. http://dx.doi.org/10.24321/2455.7048.202004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Cho, Sung-il. "The coronavirus disease 2019 pandemic and chronic diseases." Journal of the Korean Medical Association 65, no. 10 (October 10, 2022): 628–31. http://dx.doi.org/10.5124/jkma.2022.65.10.628.

Full text

Abstract:

Background: Chronic diseases contribute to 74% of annual global deaths. The coronavirus disease (COVID-19) pandemic further aggravated the burden of chronic diseases. The reasons for this adverse impact must be elucidated to develop an appropriate response.Current Concepts: COVID-19 increases the burden of chronic disease in three ways. First, chronic disease comorbidities are associated with a higher severity and fatality rate in patients with COVID-19. Second, the post COVID-19 condition results in chronic health problems. Lastly, a disruption in the system for chronic disease screening and care was observed during the COVID-19 pandemic.Discussion and Conclusion: Strong efforts are needed to mitigate the impact of the COVID-19 pandemic on chronic diseases, and to re-establish an effective system for chronic disease management.

APA, Harvard, Vancouver, ISO, and other styles

20

Bharati, Joyita, and Raja Ramachandran. "Nephrology and Coronavirus Disease 2019." Annals of the National Academy of Medical Sciences (India) 56, no. 03 (July 2020): 166–70. http://dx.doi.org/10.1055/s-0040-1714442.

Full text

Abstract:

AbstractNovel coronavirus disease 2019 (COVID-19) has emerged as a threat to the human population worldwide. Old age and presence of comorbidities are risk factors for severe complications of the disease, as many of these patients are not able to mount effective or have an aberrant antiviral response. Patients with chronic kidney disease are at high risk of COVID-19 and its complications, especially those with end-stage renal disease (ESRD). Patients have repeated exposure to crowding in dialysis units, and face the uncertainties of health care system sustainability during periods of increasing demand and scarce supply. Acute kidney injury (AKI) is a notable complication in patients with COVID-19 with an incidence of up to 25% in specific populations. Patients with AKI have a higher mortality rate. The etiology and pathogenesis of AKI in COVID-19 are multifactorial. Direct viral invasion and cytopathic effects on renal tubular cells and indirect factors like hypovolemia, rhabdomyolysis, renal vein congestion, and hypercoagulable state play a role in causing AKI in these patients. Renal replacement therapy in the form of continuous renal replacement therapy is most widely used worldwide mostly due to hemodynamic instability of critically sick patients with COVID-19. Anticoagulation therapy is critical as most COVID-19 patients have increased clotting tendency and extracorporeal circuit thrombosis is common. ESRD patients in China had mild-to-moderate symptoms commonly. However, the data from Spain and Italy report a higher mortality rate in ESRD patients than the general population. Strict screening and uniform adherence to infection control practices have led to a decreased risk of cross-infection among other patients and dialysis personnel in dialysis units. The association between nephrology and COVID-19 is unique and focus on further research on kidney pathology along with the strengthening of existing dialysis facilities are needed.

APA, Harvard, Vancouver, ISO, and other styles

21

Apituley, Tracy L. D., Damajanty H. C. Pangemanan, and Ivonny M. Sapulete. "Pengaruh Olahraga Terhadap Coronavirus Disease 2019." Jurnal Biomedik:JBM 13, no. 1 (March 15, 2021): 111. http://dx.doi.org/10.35790/jbm.13.1.2021.31752.

Full text

Abstract:

Abstract: Coronavirus disease 2019 (COVID-19) is a disease that attacks the respiratory tract. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 cases in the world and Indonesia continue to increase, and people are urged to do activities at home. COVID-19 caused a decrease in physical activity in society which can cause people to spend more time on cell phones, have irregular sleep patterns, and gain weight. Lack of physical activity has an impact on decreasing immune system, making it susceptible to infection with COVID-19. Research shows that exercise can reduce the risk of disease. This literature review aims to determine the effect of exercise on the 2019 coronavirus disease. The research method used is in the form of a literature review with data searches using three databases, which is Pubmed, Google Scholar, and ClinicalKey. The keywords used were Sport OR Physical Activity OR Exercise AND COVID-19 OR Coronavirus 2019. After being selected based on inclusion and exclusion criteria, there were 12 journal article reviews that would be reviewed. The results showed exercise can improve the immune system, metabolic health, mental health, muscle strength and cardiovascular function. The benefits of exercise are obtained if you do moderate intensity exercise regularly. In general, the recommended sports are aerobic and anaerobic exercises that can be done at home. In conclusion, exercise has a good effect on COVID-19.Keywords: Sports, Coronavirus disease 2019 (COVID-19) Abstrak: Coronavirus disease 2019 (COVID-19) merupakan penyakit yang menyerang saluran pernapasan. COVID-19 disebabkan oleh severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Kasus COVID-19 di dunia dan Indonesia terus meningkat sehingga dihimbaukan kepada masyarakat untuk melakukan aktivitas di rumah saja. COVID-19 mengakibatkan penurunan aktivitas fisik pada masyarakat yang dapat menyebabkan lebih banyak menghabiskan waktu di handphone, memiliki pola tidur tidak teratur, dan terjadi peningkatan berat badan. Kurang melakukan aktivitas fisik berdampak terhadap penurunan daya tahan tubuh sehingga rentan terinfeksi COVID-19. Penelitian-penelitian menunjukkan olahraga mampu menurunkan risiko penyakit. Tinjauan pustaka ini bertujuan untuk mengetahui pengaruh olahraga terhadap coronavirus disease 2019. Metode penelitian yang digunakan dalam bentuk literature review dengan pencarian data menggunakan tiga database yaitu Pubmed, Google Scholar, dan ClinicalKey. Kata kunci yang digunakan yaitu Sport OR Physical Activity OR Exercise AND COVID-19 OR Coronavirus 2019. Setelah diseleksi berdasarkan kriteria inklusi dan eksklusi didapatkan 12 jurnal article review yang akan dilakukan review. Hasil dari literature review didapatkan olahraga mampu meningkatkan sistem imunitas, kesehatan metabolik, kesehatan mental, kekuatan otot dan fungsi kardiovaskular. Manfaat olahraga diperoleh jika melakukan olahraga intensitas sedang dengan teratur. Secara umum olahraga yang disarankan yaitu olahraga aerobik dan anaerobik yang dapat dilakukan dirumah. Sebagai simpulan, olahraga memberi pengaruh yang baik terhadap COVID-19.Kata Kunci: Olahraga, Coronavirus disease 2019 (COVID-19)

APA, Harvard, Vancouver, ISO, and other styles

22

Baloch, Saira, Mohsin Ali Baloch, Tianli Zheng, and Xiaofang Pei. "The Coronavirus Disease 2019 (COVID-19) Pandemic." Tohoku Journal of Experimental Medicine 250, no. 4 (2020): 271–78. http://dx.doi.org/10.1620/tjem.250.271.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Santantonio, Teresa A., and Giovanni Messina. "Update on Coronavirus Disease 2019 (COVID-19)." Open Neurology Journal 14, no. 1 (April 5, 2020): 4–5. http://dx.doi.org/10.2174/1874205x02014010004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Bilichenko, T. N. "Epidemiology of Coronavirus disease 2019 (COVID-19)." Academy of medicine and sports 1, no. 2 (December 18, 2020): 14–20. http://dx.doi.org/10.15829/2712-7567-2020-2-15.

Full text

Abstract:

An analysis of epidemiology coronavirus disease 2019 (COVID-19) in Russia and the world was carried out to identify the main factors contributing to morbidity and mortality due to COVID-19, pathogenesis and clinical manifestations of the disease. Statistical data were used from official sources (Rospotrebnadzor, WHO, US CDC, China NHC, ECDC, DXY). Research information from different countries about the course, outcomes, spread, and risk factors of the disease is presented.The study of epidemiology, risk factors, causes of increased incidence of COVID-19, mortality rate is of great importance for assessing the effectiveness of preventive measures.

APA, Harvard, Vancouver, ISO, and other styles

25

Nasonov, E. L. "Coronavirus disease 2019 (COVID-19) and autoimmunity." Rheumatology Science and Practice 59, no. 1 (March 3, 2021): 5–30. http://dx.doi.org/10.47360/1995-4484-2021-5-30.

Full text

Abstract:

The coronavirus 2019 pandemic (coronavirus disease, COVID-19), etiologically related to the SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus-2), has once again reawakened healthcare professionals’ interest towards new clinical and conceptual issues of human immunology and immunopathology. An unprecedented number of clinical trials and fundamental studies of epidemiology, virology, immunology and molecular biology, of the COVID-19 clinical course polymorphism and pharmacotherapy have been conducted within one year since the outbreak of 2019 pandemic, bringing together scientists of almost all biological and physicians of almost all medical specialties. Their joint efforts have resulted in elaboration of several types of vaccines against SARS-CoV-2 infection and, in general, fashioning of more rational approaches to patient management. Also important for COVID-19 management were all clinical trials of biologics and “targeted” anti-inflammatory drugs modulating intracellular cytokine signaling, which have been specifically developed for treatment immune-mediated inflammatory rheumatic disease (IMIRDs) over the past 20 years. It became obvious after a comprehensive analysis of the entire spectrum of clinical manifestations and immunopathological disorders in COVID-19 is accompanied by a wide range of extrapulmonary clinical and laboratory disorders, some of which are characteristic of IMIRDs and other autoimmune and auto-in-flammatory human diseases. All these phenomena substantiated the practice of anti-inflammatory drugs repurposing with off-label use of specific antirheumatic agents for treatment of COVID-19. This paper discusses potential use of glucocorticoids, biologics, JAK inhibitors, etc., blocking the effects of pro-inflammatory cytokines for treatment of COVID-19.

APA, Harvard, Vancouver, ISO, and other styles

26

Bhattacharya, Koushik, Soumita Bhattacharya, Pallav Sengupta, Sulagna Dutta, Gargi Ray Choudhuri, and Lipika Das Mukhopadhyay. "Coronavirus Disease 2019 (COVID-19) and Pregnancy." Biomedical and Pharmacology Journal 14, no. 3 (September 30, 2021): 1161–74. http://dx.doi.org/10.13005/bpj/2219.

Full text

Abstract:

Women perhaps are more exposed to coronavirus disease 2019 (COVID-19), caused by the novel coronavirus (CoV) called as the severe acute respiratory syndrome-CoV-2 (SARS-CoV-2), as compared to men, due to their greater contribution in healthcare and social services. Globally, around 70% of health and social service providers constitute of female. The pandemic is also poising serious threat to female sexual and reproductive health. Particularly, pregnant women are at risk and need special antenatal care besides routine health services. SARS-CoV-2 infection leads to the path of an exaggerated immune reaction in an infected individual. This leads to ‘cytokine storm’ causing massive tissue damage, systemic inflammation, increased body temperature, and in turn, these may lead to multiple organ failure. The gonads are also susceptible to damage and impairment in reproductive functions. Thus, it is vital to acquire information on the impact of this virus on gestational changes and pregnancy outcome. Given the limitation of data on COVID-19 mediated changes in pregnant women, this article also reviews the effects of two previous coronavirus infections - severe acute respiratory syndrome (SARS) caused by SARS-CoV and the Middle East respiratory syndrome (MERS) caused by MERS-CoV to predict the possible impact of the novel SARS-CoV-2 on pregnancy outcomes. Analysis of available literature reveals that unlike coronavirus infections of pregnant women caused by SARS and MERS, COVID-19 seems less likely to cause maternal death. Importantly, alike SARS and MERS, there were no confirmed cases of intrauterine transmission of SARS-CoV-2 from mothers with COVID-19 to their fetuses. Further broad-spectrum research is necessary to reach a consensus regarding the vertical transmission of SARS-CoV-2 and whether it adopts any other mechanisms to affect pregnancy outcomes.

APA, Harvard, Vancouver, ISO, and other styles

27

Suzuki, Keisuke. "Coronavirus disease 2019 (COVID-19) and headaches." Rinsho Shinkeigaku 60, no. 9 (2020): 589–96. http://dx.doi.org/10.5692/clinicalneurol.cn-001490.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Soman, SumanOmana, and MuneerAbdul Rahaman. "Chloroquine for coronavirus disease 2019 (COVID-19)?" Annals of Clinical Cardiology 2, no. 1 (2020): 47. http://dx.doi.org/10.4103/accj.accj_3_20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Jotz, Geraldo Pereira, Richard Louis Voegels, and Ricardo Ferreira Bento. "Otorhinolaryngologists and Coronavirus Disease 2019 (COVID-19)." International Archives of Otorhinolaryngology 24, no. 02 (April 2020): e125-e128. http://dx.doi.org/10.1055/s-0040-1709724.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Rasmussen, Sonja A., and Denise J. Jamieson. "Coronavirus Disease 2019 (COVID-19) and Pregnancy." Obstetrics & Gynecology 135, no. 5 (May 2020): 999–1002. http://dx.doi.org/10.1097/aog.0000000000003873.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Parodi, Aurora, and Emanuele Cozzani. "Coronavirus disease 2019 (COVID 19) and Malaria." Medical Hypotheses 143 (October 2020): 110036. http://dx.doi.org/10.1016/j.mehy.2020.110036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

jafari-sales, abolfazl, Homeira Khaneshpour, Mehrdad Pashazadeh, and Rozita Nasiri. "Coronavirus Disease 2019 (COVID-19): review study." Jorjani Biomedicine Journal 8, no. 1 (March 1, 2020): 4–10. http://dx.doi.org/10.29252/jorjanibiomedj.8.1.4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Li, Yiwei, Qianping Weng, Xilian Huang, Yaping Xie, Can Chen, and Shenxian Qian. "Coronavirus disease 2019 (COVID-19) related cytopenia." Medicine 99, no. 36 (September 4, 2020): e22033. http://dx.doi.org/10.1097/md.0000000000022033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Habas, Khaled, Chioma Nganwuchu, Fanila Shahzad, Rajendran Gopalan, Mainul Haque, Sayeeda Rahman, Anwarul Azim Majumder, and Talat Nasim. "Resolution of coronavirus disease 2019 (COVID-19)." Expert Review of Anti-infective Therapy 18, no. 12 (August 4, 2020): 1201–11. http://dx.doi.org/10.1080/14787210.2020.1797487.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Livingston, Edward, and Karen Bucher. "Coronavirus Disease 2019 (COVID-19) in Italy." JAMA 323, no. 14 (April 14, 2020): 1335. http://dx.doi.org/10.1001/jama.2020.4344.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Desai, Angel N., and David M. Aronoff. "Masks and Coronavirus Disease 2019 (COVID-19)." JAMA 323, no. 20 (May 26, 2020): 2103. http://dx.doi.org/10.1001/jama.2020.6437.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Parke, David W. "Ophthalmology After Coronavirus Disease 2019 (COVID-19)." JAMA Ophthalmology 138, no. 6 (June 1, 2020): 599. http://dx.doi.org/10.1001/jamaophthalmol.2020.2004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Delang, Leen, and Johan Neyts. "Medical treatment options for COVID-19." European Heart Journal: Acute Cardiovascular Care 9, no. 3 (April 2020): 209–14. http://dx.doi.org/10.1177/2048872620922790.

Full text

Abstract:

Therapeutic options for coronavirus disease 2019 are desperately needed to respond to the ongoing severe acute respiratory syndrome coronavirus 2 pandemic. Both antiviral drugs and immunomodulators might have their place in the management of coronavirus disease 2019. Unfortunately, no drugs have been approved yet to treat infections with human coronaviruses. As it will take years to develop new therapies for severe acute respiratory syndrome coronavirus 2, the current focus is on the repurposing of drugs that have been approved or are in development for other conditions. Several clinical trials have already been conducted or are currently ongoing to evaluate the efficacy of such drugs. Here, we discuss the potential of these therapies for the treatment of coronavirus disease 2019.

APA, Harvard, Vancouver, ISO, and other styles

39

Cha, Hyun-Hwa, and Won Joon Seong. "Coronavirus Disease 2019 and Pregnancy." Journal of The Korean Society of Maternal and Child Health 25, no. 1 (January 31, 2021): 10–20. http://dx.doi.org/10.21896/jksmch.2021.25.1.10.

Full text

Abstract:

With the continued fight against coronavirus disease 2019 (COVID-19), new guidelines on its management are emerging; however, information on COVID-19 and pregnancy remains limited. Therefore, this study aimed to review the guidelines of the American College of Obstetricians and Gynecologists, Society for Maternal Fetal Medicine, and Royal College Obstetrics and Gynecology and International Society of Ultrasound in Obstetrics and Gynecology.

APA, Harvard, Vancouver, ISO, and other styles

40

Darmadi, Darmadi, and Riska Habriel Ruslie. "Coronavirus Disease-2019 and Mental Health." Open Access Macedonian Journal of Medical Sciences 8, T1 (October 5, 2020): 268–71. http://dx.doi.org/10.3889/oamjms.2020.5304.

Full text

Abstract:

BACKGROUND: Coronavirus disease-2019 (COVID-19) emerges in Wuhan, China and becomes a pandemic on March 2020. Its manifestations mainly cover respiratory and gastrointestinal symptoms. In fact, mental health disorders are common in patients with COVID-19 but receive minimum attention. AIM: We aimed to discuss mental health disturbances in relation to COVID-19 and its management. MATERIALS AND METHODS: We gathered literature regarding the topic from electronic sources, including PubMed and Google Scholar. RESULTS: There are several pathogeneses proposed regarding the incidence of mental health problems. The symptoms of mental health problems vary widely and also affect health-care personnel. Diagnosing mental health problem in COVID-19 patients is quite difficult because no examinations are specific enough. The management of mental health problems includes psychological and medical managements. CONCLUSION: Further study regarding mental health problem and its management in patients with COVID-19 is mandatory.

APA, Harvard, Vancouver, ISO, and other styles

41

Musheyev, Yakubmiyer, Farage Ftiha, and Henry Jradeh. "Relationship between coronavirus disease 2019 and Parkinson’s disease." International Journal of Research in Medical Sciences 9, no. 12 (November 26, 2021): 3756. http://dx.doi.org/10.18203/2320-6012.ijrms20214735.

Full text

Abstract:

New literature shows that COVID-19 has negative effects on patients with Parkinson’s disease (PD). COVID-19 is known to produce neurological manifestations and infects the central nervous system. Similarly, the virus also causes neuromuscular complications and involves the peripheral nervous system. Studies show PD patients with a severe COVID-19 infection have a higher mortality rate, worsening in symptoms, and require an increase in drug dosage. These studies suggest that COVID-19 may lead to a more rapid onset of PD, or may increase the risk of developing PD. Furthermore, researchers observed that Motor and nonmotor symptoms significantly worsened in PD patients with COVID compared to PD patients.

APA, Harvard, Vancouver, ISO, and other styles

42

Ibrahim, Bashar, and Ebru Önem. "CORONAVIRUS DISEASE 2019 (COVID-19): A LITERATURE REVIEW." Gevher Nesibe Journal IESDR 6, no. 12 (May 25, 2021): 56–72. http://dx.doi.org/10.46648/gnj.200.

Full text

Abstract:

In early December 2019, an outbreak of coronavirus 2019 (COVID-19) caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) occurred in Wuhan, China's Hubei province. On 30 January 2020, the World Health Organization and International Public Health declared the outbreak an emergency, and as of 23.03.2021, laboratory-approved 123,097,155 cases and 2,716,151 deaths were reported worldwide. The perceived risk of disease has led many countries to adopt various control measures. Emerging genetic and clinical evidence suggests a pathway similar to SARS and MERS. Potential therapeutic strategies that are currently being evaluated derive mainly from previous experience with Covid-19 treatment. Although several potential treatments for COVID-19 with SARS and MERS have been identified in animal and in vitro models, human clinical trials are still lacking, which hinders the progress of potential measures. This review requires an overview of the three major deadly coronaviruses and an assessment of risk factors applicable lessons to stop their spread by leveraging lessons learned from the first two deadly coronavirus outbreaks by identifying areas for improvement in future preparedness plans. The first lessons from the persistence and spread of the outbreak can help inform public health officials and medical practitioners in their efforts to combat its progress. Also, in this review, the pathogenesis, epidemiology, diagnosis, treatment, and vaccine strategies of the disease are reviewed.

APA, Harvard, Vancouver, ISO, and other styles

43

Mandal, Prabir. "COVID-19 Pandemic, Disparity and Vaccine: An Update." Biotechnology and Bioprocessing 2, no. 1 (February 1, 2021): 01–03. http://dx.doi.org/10.31579/2766-2314/020.

Full text

Abstract:

Coronaviruses are a diverse group of viruses infecting many different animals, and they can cause mild to severe respiratory infections in humans. In 2002 and 2012, respectively, two highly pathogenic coronaviruses with zoonotic origin, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), emerged in humans and caused fatal respiratory illness, making emerging coronaviruses a new public health concern in the twenty-first century1. In early December 2019, an outbreak of coronavirus disease 2019 (COVID-19), caused by a novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), occurred in Wuhan City, Hubei Province, China. On January 30, 2020 the World Health Organization declared the outbreak as a Public Health Emergency of International Concern. As of February 14, 2020, 49,053 laboratory-confirmed and 1,381 deaths have been reported globally.

APA, Harvard, Vancouver, ISO, and other styles

44

Tagaev, Tugolbai. "Potential Effects of Adjuvant Treatments on Coronavirus Disease 2019 (COVID-19)." Journal of Communicable Diseases 52, no. 02 (July 9, 2020): 46–49. http://dx.doi.org/10.24321/0019.5138.202022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Indri Seta Septadina. "HEALTHY LIVING PATTERNS TO PREVENT COVID-19." Conferences of Medical Sciences Dies Natalis Faculty of Medicine Universitas Sriwijaya 2, no. 1 (November 12, 2020): 107–12. http://dx.doi.org/10.32539/dies.v2i1.47.

Full text

Abstract:

Viruses are one of the causes of infectious diseases that need to be watched out for. In the last 20 years, several viral diseases have caused epidemics such as severe acute respiratory syndrome coronavirus (SARS-CoV) in 2002-2003, influenza H1N1 in 2009 and Middle East Respiratory syndrome (MERS-CoV) which was first identified in Saudi Arabia in year 2012. On December 31, 2019, China reported a case of mysterious pneumonia of unknown cause. Within 3 days, the number of patients with these cases was 44 patients and continues to increase until now there are millions of cases. Initially, the epidemiological data showed that 66% of patients were related to or exposed to a seafood market or live market in Wuhan, Hubei Province, China. Samples of isolates from patients were studied with the results showing the presence of coronavirus infection, a new type of betacoronavirus, named 2019 novel Coronavirus (2019-nCoV). On February 11, 2020, the World Health Organization named the new virus SARS-CoV-2 and the disease name as Coronavirus Disease 2019 (COVID-19). The corona virus is the main pathogen causing an outbreak of respiratory disease. On March 11, 2020, WHO announced that COVID-19 was becoming a pandemic in the world.

APA, Harvard, Vancouver, ISO, and other styles

46

Hasan, Refli. "Cardiovascular Aspects of Coronavirus Disease-2019." Open Access Macedonian Journal of Medical Sciences 9, F (January 20, 2021): 36–40. http://dx.doi.org/10.3889/oamjms.2021.5598.

Full text

Abstract:

Coronavirus disease-2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus-2. The disease has become a pandemic since March 11, 2020, with more than 47 million cases and 1 million deaths worldwide. Besides affecting respiratory system, the disease is also affects cardiovascular system. Cardiovascular involvement is hypothesized from direct invasion, inflammation, thrombosis, autoantibody, and imbalance of oxygen supply and demand. Cardiovascular damage from those processes manifests as acute coronary syndrome, arrhythmia, and heart failure. Patients contracting COVID-19 with cardiovascular manifestations should undergo routine examinations and auxiliary examinations such as cardiac biomarkers, cardiac imaging, electrocardiography, echocardiography, and angiography. COVID-19 patients with cardiovascular manifestations are managed with supportive treatment, antivirals, hydroxychloroquine, and azithromycin. Immunomodulators and convalescent plasma are being investigated recently. Anticoagulant is utilized to manage coagulopathy. Survived COVID-19 patients with history of cardiovascular manifestations should undergo routine follow-up.

APA, Harvard, Vancouver, ISO, and other styles

47

D S, Ghotekar, Vishal N Kushare, and Sagar V. Ghotekar. "Current updates on COVID-19 - A review." International Journal of Novel Trends in Pharmaceutical Sciences 10, no. 1 (April 5, 2020): 1–8. http://dx.doi.org/10.26452/ijntps.v10i1.1141.

Full text

Abstract:

Coronaviruses are a family of viruses that cause illness such as respiratory diseases or gastrointestinal diseases. Respiratory diseases can range from the common cold to more severe diseases. A novel coronavirus outbreak was first documented in Wuhan, Hubei Province, China in December 2019. The World Health Organization (WHO) has declared the coronavirus disease 2019 (COVID-19) a pandemic. A global coordinated effort is needed to stop the further spread of the virus. A novel coronavirus (nCoV) is a new strain that has not been identified in humans previously. Once scientists determine exactly what coronavirus it is, they give it a name (as in the case of COVID-19, the virus causing it is SARS-CoV-2).

APA, Harvard, Vancouver, ISO, and other styles

48

Cava, Antonio La. "Systemic lupus erythematosus and coronavirus disease 2019." Rheumatology and Immunology Research 2, no. 1 (March 1, 2021): 15–18. http://dx.doi.org/10.2478/rir-2021-0004.

Full text

Abstract:

Abstract Coronavirus disease 2019 (COVID-19) is a contagious infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It manifests with variable clinical pictures ranging from asymptomatic to mild or uncomplicated illness to severe disease with possible multi-organ involvement, with respiratory and vascular systems being the most often affected. Since COVID-19 can affect patients with autoimmune rheumatic conditions, the concomitant presence of two diseases may have clinical characteristics whose knowledge may help facilitate clinical management. This review discusses the data available in the literature on COVID-19 in systemic lupus erythematosus (SLE) patients.

APA, Harvard, Vancouver, ISO, and other styles

49

Parauba, Mercy C. K., Joudy Gessal, and Christopher Lampah. "Rehabilitasi Medik pada Pasien Coronavirus Disease 2019." Medical Scope Journal 3, no. 1 (May 6, 2021): 83. http://dx.doi.org/10.35790/msj.v3i1.33780.

Full text

Abstract:

Abstract: COVID-19 could cause respiratory, physical and psychological dysfunctions. These dysfunctions reduce the patient's functional capacity ultimately. Changes in physical function over a period of hospitalizations and critical illness are more common occurr in patients with more severe or pre-existing disease comorbidities which often lead to mobility disabilities and restrictions in activities of daily life. Physical medicine and medical rehabilitation play an impor-tant role in increasing the functional capacity of COVID-19 patients. This study was aimed to eva-luate the rehabilitation of COVID-19 patients. This was a literature review study using databases of Clinical Key, Web of Science, Pub Med, and Google Schoolar. The keywords used were rehabilitation COVID-19 OR rehabilitation SARS-CoV-2. Based on inclusion and exclusion criteria, eight literatures were selected. The result showed that early rehabilitation should be grant-ed to inpatients with COVID-19. Patients with restricted mobility due to quarantine or lockdown should receive exercise programs to reduce the risk of frailty, sarcopenia, cognitive decline, and depression. Telerehabilitation may represent the first option for individuals at home. In conclusion, proper rehabilitation can reduce the consequences of decreasing functional capacity.Keywords: rehabilitation; COVID-19 patients Abstrak; COVID-19 dapat menyebabkan disfungsi pernapasan, fisik, dan psikologis yang menurunkan kapasitas fungsional pasien. Perubahan fungsi fisik selama periode rawat inap dan penyakit kritis lebih umum dialami oleh pasien dengan penyakit COVID-19 yang lebih parah atau disertai komorbiditas dan dapat berakibat cacat mobilitas dan pembatasan dalam aktivitas kehi-dupan sehari-hari. Kedokteran fisik dan rehabilitasi medik memiliki peran penting dalam mening-katkan kapasitas fungsional pasien COVID-19. Penelitian ini bertujuan untuk mengetahui peran rehabilitasi medik pada pasien COVID-19. Jenis penelitian ialah literature review menggunakan database Clinical Key, Web of Science, PubMed, dan Google Scholar. Kata kunci yang digunakan yaitu rehabilitasi COVID-19 OR rehabilitasi SARS-CoV-2. Seleksi data berdasarkan kriteria inklusi dan ekslusi mendapatkan delapan literatur. Hasil penelitian menunjukkan bahwa rehabilitasi dini harus diberikan kepada pasien rawat inap dengan COVID-19. Pasien dengan mobilitas terbatas karena karantina atau lockdown harus menerima latihan program untuk mengurangi risiko kelemahan, sarkopenia, penurunan kognitif, dan depresi. Telerehabilitasi mungkin merupakan pilihan pertama bagi individu di rumah. Simpulan penelitian ini ialah rehabilitasi dini yang tepat dapat mengurangi konsekuensi penurunan kapasitas fungsional.Kata kunci: rehabilitasi; pasien COVID-19

APA, Harvard, Vancouver, ISO, and other styles

50

Parauba, Mercy C. K., Joudy Gessal, and Christopher Lampah. "Rehabilitasi Medik pada Pasien Coronavirus Disease 2019." Medical Scope Journal 3, no. 1 (May 6, 2021): 83. http://dx.doi.org/10.35790/msj.3.1.2021.33780.

Full text

Abstract:

Abstract: COVID-19 could cause respiratory, physical and psychological dysfunctions. These dysfunctions reduce the patient's functional capacity ultimately. Changes in physical function over a period of hospitalizations and critical illness are more common occurr in patients with more severe or pre-existing disease comorbidities which often lead to mobility disabilities and restrictions in activities of daily life. Physical medicine and medical rehabilitation play an impor-tant role in increasing the functional capacity of COVID-19 patients. This study was aimed to eva-luate the rehabilitation of COVID-19 patients. This was a literature review study using databases of Clinical Key, Web of Science, Pub Med, and Google Schoolar. The keywords used were rehabilitation COVID-19 OR rehabilitation SARS-CoV-2. Based on inclusion and exclusion criteria, eight literatures were selected. The result showed that early rehabilitation should be grant-ed to inpatients with COVID-19. Patients with restricted mobility due to quarantine or lockdown should receive exercise programs to reduce the risk of frailty, sarcopenia, cognitive decline, and depression. Telerehabilitation may represent the first option for individuals at home. In conclusion, proper rehabilitation can reduce the consequences of decreasing functional capacity.Keywords: rehabilitation; COVID-19 patients Abstrak; COVID-19 dapat menyebabkan disfungsi pernapasan, fisik, dan psikologis yang menurunkan kapasitas fungsional pasien. Perubahan fungsi fisik selama periode rawat inap dan penyakit kritis lebih umum dialami oleh pasien dengan penyakit COVID-19 yang lebih parah atau disertai komorbiditas dan dapat berakibat cacat mobilitas dan pembatasan dalam aktivitas kehi-dupan sehari-hari. Kedokteran fisik dan rehabilitasi medik memiliki peran penting dalam mening-katkan kapasitas fungsional pasien COVID-19. Penelitian ini bertujuan untuk mengetahui peran rehabilitasi medik pada pasien COVID-19. Jenis penelitian ialah literature review menggunakan database Clinical Key, Web of Science, PubMed, dan Google Scholar. Kata kunci yang digunakan yaitu rehabilitasi COVID-19 OR rehabilitasi SARS-CoV-2. Seleksi data berdasarkan kriteria inklusi dan ekslusi mendapatkan delapan literatur. Hasil penelitian menunjukkan bahwa rehabilitasi dini harus diberikan kepada pasien rawat inap dengan COVID-19. Pasien dengan mobilitas terbatas karena karantina atau lockdown harus menerima latihan program untuk mengurangi risiko kelemahan, sarkopenia, penurunan kognitif, dan depresi. Telerehabilitasi mungkin merupakan pilihan pertama bagi individu di rumah. Simpulan penelitian ini ialah rehabilitasi dini yang tepat dapat mengurangi konsekuensi penurunan kapasitas fungsional.Kata kunci: rehabilitasi; pasien COVID-19

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!